Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Ana Vujovic

Concepts (112)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
4
2025
702
0.800
Why?
Hematopoietic Stem Cells
4
2026
432
0.500
Why?
Neoplastic Stem Cells
3
2025
403
0.410
Why?
Oxidative Stress
7
2014
1369
0.380
Why?
Receptors, Aryl Hydrocarbon
2
2025
61
0.360
Why?
Clinical Laboratory Techniques
1
2010
96
0.290
Why?
Hypercholesterolemia
1
2010
95
0.290
Why?
Data Interpretation, Statistical
1
2010
368
0.270
Why?
Cholesterol, LDL
1
2010
363
0.270
Why?
Aryldialkylphosphatase
6
2014
17
0.250
Why?
Niacinamide
1
2026
103
0.230
Why?
Membrane Potential, Mitochondrial
1
2025
75
0.230
Why?
Myelodysplastic Syndromes
1
2026
170
0.210
Why?
Hematopoiesis
2
2022
195
0.200
Why?
ELAV-Like Protein 1
1
2023
17
0.190
Why?
Leukemia
1
2025
246
0.190
Why?
Molecular Targeted Therapy
1
2025
447
0.180
Why?
RNA Splicing Factors
1
2022
66
0.170
Why?
Rho Guanine Nucleotide Exchange Factors
1
2021
27
0.170
Why?
Antioxidants
2
2014
544
0.140
Why?
Lipids
4
2012
714
0.140
Why?
RNA-Binding Proteins
1
2023
465
0.140
Why?
Atherosclerosis
2
2012
410
0.140
Why?
Cell Differentiation
2
2023
1982
0.130
Why?
Transcription Factors
1
2025
1730
0.130
Why?
Antineoplastic Agents
1
2025
2219
0.100
Why?
Serbia
2
2011
7
0.100
Why?
Hyperlipidemias
1
2012
120
0.090
Why?
Reference Values
2
2011
796
0.090
Why?
Cell Line, Tumor
3
2025
3545
0.090
Why?
Volleyball
1
2011
9
0.080
Why?
Physical Education and Training
1
2011
72
0.080
Why?
Malnutrition
1
2012
87
0.080
Why?
Signal Transduction
2
2025
5246
0.080
Why?
Smoking
2
2014
1486
0.080
Why?
Humans
16
2026
146342
0.070
Why?
Lipoproteins
1
2010
165
0.070
Why?
Weight Gain
1
2012
562
0.070
Why?
Reactive Oxygen Species
1
2011
610
0.070
Why?
Lipoproteins, LDL
1
2008
119
0.070
Why?
Lipoproteins, HDL
1
2008
104
0.070
Why?
Nicotinamide Phosphoribosyltransferase
1
2026
26
0.060
Why?
Pregnancy
3
2014
7230
0.060
Why?
Kidney Failure, Chronic
1
2012
589
0.060
Why?
Renal Insufficiency, Chronic
1
2012
640
0.060
Why?
Coronary Disease
1
2008
380
0.060
Why?
Asparagine
1
2025
34
0.060
Why?
Cardiolipins
1
2025
83
0.050
Why?
Proto-Oncogene Proteins c-myc
1
2025
157
0.050
Why?
Protein Biosynthesis
1
2025
449
0.050
Why?
Xenograft Model Antitumor Assays
1
2025
930
0.040
Why?
Mice
3
2025
18297
0.040
Why?
Reproducibility of Results
1
2010
3416
0.040
Why?
Coronary Artery Disease
1
2008
751
0.040
Why?
Malondialdehyde
2
2012
31
0.040
Why?
Spindle Apparatus
1
2021
93
0.040
Why?
Inflammation
2
2012
2919
0.040
Why?
Bone Marrow Cells
1
2021
328
0.040
Why?
Case-Control Studies
3
2012
3647
0.040
Why?
Drug Resistance, Neoplasm
1
2025
893
0.040
Why?
Regression Analysis
2
2012
999
0.040
Why?
Linear Models
2
2012
857
0.040
Why?
Adult
6
2014
41087
0.040
Why?
Proteins
1
2025
1022
0.040
Why?
Mitochondria
1
2025
997
0.040
Why?
Cytokines
1
2026
2081
0.030
Why?
Dietary Supplements
2
2014
587
0.030
Why?
Renal Dialysis
2
2012
461
0.030
Why?
Female
8
2014
79499
0.030
Why?
Animals
3
2025
38107
0.030
Why?
Phenotype
3
2011
3206
0.030
Why?
Proteomics
1
2022
1203
0.030
Why?
Promoter Regions, Genetic
1
2019
1242
0.030
Why?
Thiobarbituric Acid Reactive Substances
1
2014
29
0.030
Why?
Middle Aged
3
2012
36619
0.020
Why?
Advanced Oxidation Protein Products
1
2012
1
0.020
Why?
Vitamins
1
2014
183
0.020
Why?
Apoptosis
1
2021
2439
0.020
Why?
Carotid Intima-Media Thickness
1
2012
75
0.020
Why?
Cell Proliferation
1
2019
2502
0.020
Why?
Male
4
2012
73396
0.020
Why?
Superoxide Dismutase
1
2012
307
0.020
Why?
Cholesterol
1
2012
411
0.020
Why?
Young Adult
3
2012
14330
0.020
Why?
Chi-Square Distribution
1
2011
517
0.020
Why?
Risk Assessment
2
2011
3712
0.020
Why?
Dyslipidemias
1
2012
184
0.020
Why?
Triglycerides
1
2012
527
0.020
Why?
Analysis of Variance
1
2012
1298
0.020
Why?
Biomarkers
2
2011
4340
0.020
Why?
Athletic Performance
1
2011
78
0.020
Why?
Kaplan-Meier Estimate
1
2012
970
0.020
Why?
Monitoring, Physiologic
1
2011
279
0.020
Why?
Paraoxon
1
2008
2
0.020
Why?
Gestational Age
1
2011
990
0.020
Why?
Oxidation-Reduction
1
2011
1075
0.020
Why?
Area Under Curve
1
2008
335
0.020
Why?
Organophosphorus Compounds
1
2008
84
0.020
Why?
Multivariate Analysis
1
2011
1543
0.020
Why?
Athletes
1
2011
432
0.020
Why?
Particle Size
1
2008
386
0.020
Why?
Kidney Transplantation
1
2012
735
0.010
Why?
Body Mass Index
1
2012
2458
0.010
Why?
Longitudinal Studies
1
2011
3017
0.010
Why?
Logistic Models
1
2008
2126
0.010
Why?
Blood Glucose
1
2011
2360
0.010
Why?
Time Factors
1
2011
7109
0.010
Why?
Prospective Studies
1
2012
8123
0.010
Why?
Cardiovascular Diseases
1
2011
2219
0.010
Why?
Risk Factors
1
2011
10921
0.010
Why?
Adolescent
1
2012
22557
0.010
Why?
Child
1
2012
22693
0.010
Why?
Vujovic's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)